- GH 0.00%
Even after rising 7.4% this past week, Guardant Health (NASDAQ:GH) shareholders are still down 74% over the past three years
Yahoo Finance · 2 weeks ago
Open | 29.51 |
High | 30.17 |
Low | 29.50 |
Mkt Cap | 3.62B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 29.56 |
52 Wk. Low | 15.81 |
52 Wk. High | 41.06 |
Related stocks
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally.
Guardant Health is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 168.49M | 30.90% ▲ |
Net Income | -114.98M | - |
Diluted EPS | -0.94 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.75 | - |
Q1 2024 | -$0.85 | -$0.94 |
Q4 2023 | -$0.86 | -$1.58 |
S&P 500^GSPC | 5,464.62-8.55 (-0.16%) |
Dow 30^DJI | 39,150.33+15.57 (+0.04%) |
Nasdaq^IXIC | 17,689.36-32.23 (-0.18%) |
S&P 500^GSPC | 5,464.62-0.16% |
NASDAQ Composite^IXIC | 17,689.36-0.18% |
Bitcoin USDBTC-USD | 64,294.00+0.39% |